Neochromosome, Inc. is a biotech startup working in the synthetic biology space. The firm's disruptive chromosome synthesis and engineering technologies are designed to address various applications that cannot be met using gene-at-a-time engineering. Neochromosome designs, builds, and optimizes entire synthetic chromosomes that augment a host cell's genetic information, analogous to upgrading a computer's operating system. Rather than piecemeal editing of an existing genome, Neo delivers entire chromosomes designed de novo to be modular and orthogonal to the host cell. A primary focus of the firm is higher eukaryotic cells as a platform for expression of commercially valuable biological pathways
